Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In a double-blind study with a placebo group, chronic insomniac patients administered with a DSIP analogue experienced a reduction in sleep latency by an average of 22 minutes, suggesting its potential as a therapeutic agent for severe chronic insomnia patients (Anderer & Saletu, 1991)
Chemiluminescence 3
Future Outlook GLP-1-based foods and medicines represent a significant opportunity for the pet industry to tackle obesity with science-backed food solutions and meet a long-standing consumer demand
Research use only A lab-only boundary
Psychiatry Clin Neurosci
US$ 23.99
US$ 24.61
US$ 27.62
US$ 29.57
